Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, MD
Clinical Trial Details
Research Study Summary
A randomized, double-blind, parallel-group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis patients with or at high risk for Cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen.
Do you have Rheumatoid Arthritis? You may qualify to participate in a clinical research study.
This is a randomized, double blind, parallel-group study of cardiovascular disease comparing Celecoxib with Naproxen and Ibuprofen. The study is for a 42 week period. The data from this trial will significantly add to our understanding of the cardiovascular safety of nonsteroidal use in our patients.
To Learn more
Both Male and Female
Date Last Changed:
July 23, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.